From the Journals

Metformin’s Potential Role in PCO

Common diabetes therapy reaches intraocular lens tissue and may help limit posterior capsule opacification, says newly published data

Share

  • 1

    Metformin may reduce posterior capsule opacification (PCO) risk.

  • 2

    PCO occurs in 20%-30% of cataract surgery patients.

  • 3

    Study involved 20 type 2 diabetes patients treated with metformin.

  • 4

    Metformin concentrations correlated between serum and lens capsule.

  • 5

    In vitro tests show reduced LEC proliferation with metformin.

  • 6

    Larger studies are needed to confirm findings.

  • 7

    Metformin's effects may indicate its role beyond diabetes management.

Original Source(s)

Metformin’s Potential Role in PCO

Common diabetes therapy reaches intraocular lens tissue and may help limit posterior capsule opacification, says newly published data

  • by Conexiant News Staff

  • March 5, 2026

  • 3 min

Related Content

Patterns of Spread in Ocular Melanoma

Study examines lymphatic and distant metastasis risk

Metformin and AMD: Signal or Noise?

Five-year population study details 37% lower incidence of intermediate AMD in type 2 diabetic patients prescribed metformin

Boris Malyugin: Power List Perspectives

Our Power Lister winners explore the major trends in their field, and the seismic impact AI and machine learning is having on the profession